{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":203,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":203,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"dc2625e1edb0","filters":{"venue":"Cancer Discovery"}},"results":[{"id":"W2763751953","doi":"10.1158/2159-8290.cd-17-0698","title":"Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1364,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Juno Therapeutics","keywords":"Neurotoxicity; Medicine; Cytokine release syndrome; Immunology; Bone marrow; Blood–brain barrier; Pericyte; Endothelium; Chimeric antigen receptor; Cancer research; Immunotherapy; Endothelial stem cell; Internal medicine; Central nervous system; Immune system; Toxicity; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01706914031407214,"gpt":0.3043987147974286,"spread":0.2873295744833565,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001690933,0.0001979742,0.000282663,0.0001067953,0.0001266251,0.000183354,0.0001179912,0.00009117803,0.0004326929],"category_scores_gemma":[0.00003544825,0.0001561088,0.00006110157,0.0000751406,0.0002712747,0.0006827267,0.00005490631,0.0003198211,0.000003098399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000180566,"about_ca_system_score_gemma":0.0002133049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001087326,"about_ca_topic_score_gemma":0.0004809887,"domain_scores_codex":[0.9987343,0.00006827261,0.0001668963,0.0003995792,0.000323186,0.000307786],"domain_scores_gemma":[0.9991278,0.00007166412,0.0001096098,0.0005379993,0.00005600739,0.00009693399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0057017,0.00009823489,0.1093533,0.00005715216,0.00008337406,0.00005833022,0.0007839753,0.00001301092,0.8776358,0.00001689944,0.00003672804,0.006161468],"study_design_scores_gemma":[0.005775846,0.0004905535,0.4691498,0.0003029887,0.00003607905,0.00001328487,0.0001391776,0.00005137812,0.521816,0.00005186816,0.001949041,0.0002239744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968907,0.0001953699,0.0001191685,0.0008432292,0.000124087,0.000964308,0.00009117692,0.0000164705,0.0007554797],"genre_scores_gemma":[0.9914401,0.0007502206,0.00003823792,0.000628761,0.0003103473,0.0003688697,0.000008831924,0.0000484792,0.006406134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3597965,"threshold_uncertainty_score":0.636593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807088563","doi":"10.1158/2159-8290.cd-18-0349","title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1094,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Lustgarten Foundation","keywords":"Pancreatic cancer; Medicine; Precision medicine; Malignancy; Oncology; Chemotherapy; Cancer; Transcriptome; Gene expression profiling; Internal medicine; Bioinformatics; Cancer research; Biology; Pathology; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.03869818411819338,"gpt":0.3906178003824897,"spread":0.3519196162642963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003205262,0.0001696429,0.0005474311,0.0002227596,0.00008941626,0.00004511491,0.0001526287,0.0001067769,0.0008633147],"category_scores_gemma":[0.0001129776,0.0001406547,0.00005751937,0.0005451781,0.0002492749,0.0001915239,0.00006071502,0.0002148546,0.00008523562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005792268,"about_ca_system_score_gemma":0.0008492261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002081363,"about_ca_topic_score_gemma":0.002681603,"domain_scores_codex":[0.9984809,0.00007379051,0.0003033852,0.0003692326,0.0003071517,0.0004655371],"domain_scores_gemma":[0.9991913,0.0001134162,0.00005914224,0.0003641302,0.000112931,0.0001590395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0019894,0.0001007044,0.9239291,0.0001540126,0.0001293196,0.0000364257,0.001601449,0.000005448941,0.06449403,0.0001061398,0.005509156,0.001944828],"study_design_scores_gemma":[0.003403083,0.0005851173,0.8715243,0.001067134,0.000164505,0.00001249938,0.001406114,0.0002998181,0.1170382,0.0004482407,0.003733134,0.0003178162],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896181,0.001231426,0.0001454759,0.004567871,0.0003104257,0.0007964084,0.00002631726,0.00003672685,0.0032673],"genre_scores_gemma":[0.9806008,0.001091635,0.0002842549,0.00311763,0.0005859518,0.0004067391,0.00001136545,0.0000383417,0.01386322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05254421,"threshold_uncertainty_score":0.945269,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130955565","doi":"10.1158/2159-8290.cd-11-0130","title":"Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets","year":2011,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1020,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Weill Cornell Medical College; U.S. Public Health Service","keywords":"Prostate cancer; Cancer research; Prostate; Biology; Aurora kinase; Cancer; Adenocarcinoma; Neuroendocrine tumors; In vivo; Medicine; Internal medicine; Cell cycle; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02261109907375157,"gpt":0.2972642332103163,"spread":0.2746531341365647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004080419,0.0001010242,0.0002148615,0.00008736309,0.00001917352,0.000009202835,0.00005113162,0.00001491006,0.00006280431],"category_scores_gemma":[0.00001013615,0.00008137622,0.00004413486,0.0001650576,0.00009705003,0.0002583021,0.00003509066,0.0000616675,8.230061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004925454,"about_ca_system_score_gemma":0.0002734854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007780542,"about_ca_topic_score_gemma":0.00001659747,"domain_scores_codex":[0.9991857,0.00001568619,0.0002584368,0.0002055864,0.0001828676,0.0001516625],"domain_scores_gemma":[0.9994573,0.000005258906,0.0001727297,0.0001776395,0.0001067239,0.00008036607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007469438,0.000101932,0.09995928,0.0004775677,0.0001148067,0.00002117429,0.00123283,0.000003160588,0.8821467,0.000135585,0.0001237255,0.01493634],"study_design_scores_gemma":[0.0009679921,0.00006975752,0.2669307,0.0001370817,0.00008843127,0.000002528262,0.00004153058,0.00003482374,0.7313556,0.00009924382,0.000216506,0.0000557849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993928,0.004433205,0.0001273411,0.0006054658,0.0001575297,0.0004833803,0.0001449407,0.00001106088,0.0001090681],"genre_scores_gemma":[0.9857869,0.009285321,0.00002173884,0.00005962101,0.00004491918,0.00007668859,0.00007924643,0.00001900366,0.004626545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1669714,"threshold_uncertainty_score":0.3318426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805523469","doi":"10.1158/2159-8290.cd-17-1319","title":"Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":924,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Emerald Foundation; Parker Institute for Cancer Immunotherapy; Alberta Emerald Foundation; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; Juno Therapeutics; Leukemia and Lymphoma Society; American Society of Hematology","keywords":"Lymphoblastic Leukemia; Neurotoxicity; Medicine; Leukemia; Cell; Cancer research; Oncology; Immunology; Biology; Internal medicine; Toxicity; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02659625784607731,"gpt":0.3056077702695786,"spread":0.2790115124235013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002206867,0.0002060785,0.0005290411,0.00008192606,0.00003881809,0.00002062434,0.0001150412,0.0001685047,0.0001805022],"category_scores_gemma":[0.00005016895,0.0001244923,0.00006323906,0.0003186906,0.0008998015,0.0001124884,0.00005529641,0.0003173231,0.000003072337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002284368,"about_ca_system_score_gemma":0.0005177131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001413289,"about_ca_topic_score_gemma":0.00007843931,"domain_scores_codex":[0.9984147,0.0001476359,0.0003335702,0.000432053,0.0003337624,0.0003383059],"domain_scores_gemma":[0.998982,0.0002733958,0.0001558797,0.0002734353,0.0001822609,0.0001330578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008759233,0.0005998213,0.9795348,0.00002138474,0.0001455091,0.00002089546,0.0001198438,0.000009137339,0.00917459,0.000001804559,0.00009245255,0.001520545],"study_design_scores_gemma":[0.01624948,0.008924246,0.9650727,0.000199686,0.00006036351,0.000001795143,0.00002986605,0.0001356484,0.00908043,0.000009789634,0.00007082629,0.0001651789],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982314,0.0002243147,0.00001849296,0.00002340413,0.00009849584,0.0007943697,0.00005988787,0.00001918468,0.0005304862],"genre_scores_gemma":[0.997807,0.0008901278,0.00001831794,0.0002430613,0.00008064821,0.00004118559,0.00002918579,0.00003397683,0.000856546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0144621,"threshold_uncertainty_score":0.5076647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2986162201","doi":"10.1158/2159-8290.cd-19-0644","title":"Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":846,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Microsemi (Canada)","funders":"Genentech","keywords":"Immunotherapy; Stromal cell; Cancer research; Tumor microenvironment; Pancreatic cancer; Cancer-Associated Fibroblasts; Cancer; Cancer immunotherapy; Adenocarcinoma; Biology; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01890761537577933,"gpt":0.322110409239435,"spread":0.3032027938636556,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003632865,0.0002116232,0.0006500377,0.0002077257,0.00005353598,0.00002114979,0.0001457194,0.0001350525,0.0003051482],"category_scores_gemma":[0.0001165873,0.0001752487,0.0001351003,0.0002907021,0.0001153129,0.0002206941,0.00008749521,0.0001969809,0.00004832264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002383009,"about_ca_system_score_gemma":0.002118209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003429288,"about_ca_topic_score_gemma":0.000140762,"domain_scores_codex":[0.9979877,0.0001920829,0.0004799528,0.0004038939,0.0004804681,0.0004558705],"domain_scores_gemma":[0.9986915,0.0002275747,0.0002139184,0.0004924706,0.0001925311,0.0001820348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009316794,0.000137566,0.1237178,0.0002627039,0.00009687386,0.00002887556,0.002184733,0.0001106641,0.8595551,0.00002369521,0.0003268606,0.004238409],"study_design_scores_gemma":[0.009234671,0.01670959,0.354129,0.006294576,0.0003722215,0.0000744813,0.004021139,0.0006293719,0.6032173,0.0004888172,0.003958605,0.0008702112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945993,0.002356037,0.0002479155,0.0005357053,0.0003172321,0.00107045,0.00003709895,0.00003101459,0.0008051895],"genre_scores_gemma":[0.9928543,0.0002365927,0.0006275879,0.0004418468,0.000110084,0.0002237689,0.000004804835,0.00005154352,0.005449492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2563378,"threshold_uncertainty_score":0.7146436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2897299514","doi":"10.1158/2159-8290.cd-18-0804","title":"Integrative Molecular Characterization of Malignant Pleural Mesothelioma","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":618,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia","funders":"National Cancer Institute; National Human Genome Research Institute; National Institutes of Health; British Lung Foundation","keywords":"Loss of heterozygosity; BAP1; Biology; Mesothelioma; Cancer research; Immune checkpoint; Immunotherapy; Immune system; Gene; Medicine; Immunology; Pathology; Genetics; Melanoma; Allele","retraction":null,"screen_n_in":null,"score":{"opus":0.009942077733318502,"gpt":0.2742646521202366,"spread":0.2643225743869181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001494784,0.00007298827,0.0001157913,0.00003422751,0.00001892451,0.000006236284,0.00003254658,0.0000209113,0.0003606998],"category_scores_gemma":[0.000007515682,0.00005161869,0.00005581655,0.00007859846,0.0001342288,0.0001425359,0.00001924237,0.00002390864,0.00002238616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005480438,"about_ca_system_score_gemma":0.0000530557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003515189,"about_ca_topic_score_gemma":0.000003285035,"domain_scores_codex":[0.9995484,0.00001027344,0.0001098237,0.0001180192,0.0001355784,0.00007790669],"domain_scores_gemma":[0.9997706,0.000005070352,0.00005472797,0.00009824061,0.00002989407,0.00004141642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003704202,0.00008741597,0.07488562,0.00004205246,0.00005793587,0.000006461681,0.0001247595,0.000001308308,0.9221988,0.0005630581,0.0001958433,0.001466334],"study_design_scores_gemma":[0.0002483938,0.0001559055,0.5935391,0.000135869,0.00005485562,0.000002311717,0.00004319828,0.0000449127,0.4051644,0.00007357352,0.0004858157,0.0000516746],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971403,0.0001624913,0.0007237571,0.0002685827,0.0001169048,0.0001221324,0.0002041412,0.000009462744,0.001252208],"genre_scores_gemma":[0.9975579,0.00008060728,0.0000381299,0.0005034072,0.0001447289,0.00002179796,0.0001440549,0.000009747963,0.00149966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5186535,"threshold_uncertainty_score":0.394941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793126529","doi":"10.1158/2159-8290.cd-17-1327","title":"Genetic Mechanisms of Immune Evasion in Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":550,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Ontario Institute for Cancer Research","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; U.S. National Library of Medicine; Ontario Ministry of Research and Innovation; Stand Up To Cancer; Dana-Farber/Harvard Cancer Center; Gary Bennett Family Fund; Parker Institute for Cancer Immunotherapy; American Association for Cancer Research; American Society of Clinical Oncology; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Hope Foundation; National Institutes of Health; Conquer Cancer Foundation; Tower Cancer Research Foundation","keywords":"Evasion (ethics); Immune system; Colorectal cancer; Cancer; Biology; Computational biology; Immunology; Cancer research; Medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01418535128695848,"gpt":0.2869981973630584,"spread":0.2728128460761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001124578,0.000133596,0.0003007251,0.0001082785,0.00003198554,0.00001088482,0.00009664975,0.0000852607,0.0007596885],"category_scores_gemma":[0.00001053378,0.0001106859,0.0001219616,0.0003226417,0.0001903535,0.0001139694,0.00003529813,0.00009260677,0.000005909981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002945385,"about_ca_system_score_gemma":0.0004031087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003692652,"about_ca_topic_score_gemma":0.001490211,"domain_scores_codex":[0.9989694,0.00002361974,0.0003339058,0.000235743,0.0002072857,0.0002300978],"domain_scores_gemma":[0.9995629,0.00001827078,0.0001186252,0.0001875333,0.00007118152,0.00004144992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003293094,0.0000979074,0.02165771,0.000103521,0.0001109193,0.000009063815,0.0004042411,0.000009045723,0.9568343,0.00007911119,0.0003722165,0.01702893],"study_design_scores_gemma":[0.00230441,0.0004540741,0.4176449,0.0005307346,0.00005432037,0.000007566363,0.0001390354,0.00008125538,0.5778681,0.0002241629,0.0005647672,0.0001266958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99102,0.006281067,0.0003412735,0.0003390225,0.0008678671,0.0003410422,0.00004451312,0.00001603989,0.0007492144],"genre_scores_gemma":[0.9962057,0.002327527,0.0001519131,0.0004042847,0.0002541841,0.0001106942,0.000005383457,0.00002343825,0.0005168456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3959871,"threshold_uncertainty_score":0.8318056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789730857","doi":"10.1158/2159-8290.cd-17-0937","title":"Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":522,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Interior Health; BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Astellas Pharma; Emil Aaltosen Säätiö; Prostate Cancer Canada; DOD Prostate Cancer Research Program; Terry Fox Research Institute; Movember Foundation; Prostate Cancer Foundation","keywords":"Enzalutamide; Prostate cancer; Abiraterone; Androgen receptor; Cancer; Liquid biopsy; Medicine; Oncology; Internal medicine; Circulating tumor cell; Cancer research; Biomarker; Cancer biomarkers; Exome sequencing; Gene; Biology; Mutation; Genetics; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.01801108254339182,"gpt":0.2996990652203911,"spread":0.2816879826769993,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000136571,0.0002229052,0.0003442725,0.0001388078,0.0001130461,0.00008406627,0.00007755506,0.00003931671,0.00005105582],"category_scores_gemma":[0.00001723905,0.0001649936,0.00002781958,0.0003967812,0.0002539523,0.0002829635,0.00007184925,0.0001981804,0.00001142453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008204933,"about_ca_system_score_gemma":0.0008316107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007967901,"about_ca_topic_score_gemma":0.0045598,"domain_scores_codex":[0.9984204,0.0000280169,0.0002478626,0.0005240918,0.0002496113,0.0005300092],"domain_scores_gemma":[0.9993083,0.00002840445,0.00008043363,0.0002651766,0.000115015,0.0002026976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01381918,0.0001910181,0.8164281,0.0009844726,0.0003659961,0.001355461,0.008995594,0.0004075936,0.14562,0.0001923903,0.001843143,0.009796992],"study_design_scores_gemma":[0.0125136,0.001362089,0.8857852,0.005473043,0.0002441366,0.00009567798,0.001347501,0.0003623674,0.07726351,0.0002727594,0.0142883,0.0009917725],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905329,0.005334952,0.00003481533,0.001679004,0.0001807196,0.0009708951,0.00009863913,0.00003182382,0.001136266],"genre_scores_gemma":[0.9889069,0.001131301,0.0002124109,0.000838414,0.0002701481,0.0004266819,0.00001325563,0.00005402733,0.008146919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06935712,"threshold_uncertainty_score":0.6728246,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146654374","doi":"10.1158/2159-8290.cd-12-0263","title":"Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning","year":2012,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":508,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Metformin; Medicine; Context (archaeology); Drug; Cancer; Pharmacology; Diabetes mellitus; Clinical trial; Dosing; Population; Intensive care medicine; Bioinformatics; Oncology; Internal medicine; Insulin; Endocrinology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06150239063818261,"gpt":0.346736745472692,"spread":0.2852343548345093,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001989006,0.0002773299,0.0005701195,0.0000208672,0.0001276504,0.00003492586,0.0002216454,0.0001690763,0.00001453408],"category_scores_gemma":[0.0000300705,0.0001417145,0.0004129352,0.00009427566,0.0002204012,0.00001442541,0.00009966899,0.00008603008,2.058506e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005744107,"about_ca_system_score_gemma":0.0006327764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001337766,"about_ca_topic_score_gemma":0.0003309459,"domain_scores_codex":[0.9989442,0.00009910144,0.0003028014,0.000292897,0.000101442,0.0002595534],"domain_scores_gemma":[0.9990326,0.00004128603,0.0004638032,0.0003785433,0.0000385277,0.0000452637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003417825,0.00001133414,0.00007344019,0.00189505,0.0003262784,1.481914e-8,0.00006505647,0.000003603433,0.00007776506,0.0001222743,0.0002479197,0.9971738],"study_design_scores_gemma":[0.000187732,0.00003846844,0.00002084903,0.001787822,0.001420097,0.000001274248,0.00002637379,0.000001481013,0.002733831,0.00007884456,0.9935312,0.0001720081],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002789316,0.9950769,0.00003013515,0.00001617669,0.0006479053,0.0008880603,0.000474542,0.000002632262,0.00007434349],"genre_scores_gemma":[0.0003358301,0.9953396,0.00003268162,0.00009985446,0.001193145,0.001665811,0.0001029033,0.00004230651,0.001187844],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9970018,"threshold_uncertainty_score":0.5778947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146542392","doi":"10.1158/2159-8290.cd-11-0194","title":"<i>ATM</i> Mutations in Patients with Hereditary Pancreatic Cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":489,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"National Cancer Institute","keywords":"Pancreatic cancer; Cancer; Genetics; Biology; Adenocarcinoma; Exome sequencing; Exome; Mutation; Cancer research; Gene; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03231327219858047,"gpt":0.310225705989058,"spread":0.2779124337904775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008030249,0.000149605,0.0004009118,0.0001098446,0.00005291072,0.000009993738,0.00008706262,0.0000769097,0.0009548843],"category_scores_gemma":[0.0000288815,0.00010757,0.00004411472,0.0002845101,0.000190687,0.0002800382,0.00002973143,0.000212377,0.00002582445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000299469,"about_ca_system_score_gemma":0.0007233073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003233486,"about_ca_topic_score_gemma":0.00126498,"domain_scores_codex":[0.9988386,0.0000403736,0.0002238245,0.0002706314,0.0002757403,0.0003508215],"domain_scores_gemma":[0.999393,0.00005661551,0.00006247266,0.0002537164,0.0001019505,0.0001322764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008055684,0.0003777575,0.9954458,0.00008953409,0.0001577994,0.00006593489,0.0007154027,0.000005731173,0.0000177335,0.00007627315,0.001145108,0.001097367],"study_design_scores_gemma":[0.003551497,0.0004101862,0.9945655,0.0003504101,0.0002587592,0.000002614399,0.0002050423,0.00003046413,0.0001211686,0.0001303894,0.0002396745,0.0001342204],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866243,0.0009591662,0.0000647854,0.0001849923,0.0001504672,0.0006125935,0.00008713116,0.00002463122,0.01129194],"genre_scores_gemma":[0.9960419,0.0002363883,0.0002950054,0.0006170844,0.0001302998,0.0005283667,0.00004972046,0.00002753656,0.002073687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009417621,"threshold_uncertainty_score":0.9999584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167264978","doi":"10.1158/2159-8290.cd-11-0039","title":"High Frequency of <i>PIK3R1</i> and <i>PIK3R2</i> Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability","year":2011,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":472,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"PTEN; PI3K/AKT/mTOR pathway; Cancer research; Endometrial cancer; Phenocopy; KRAS; Biology; Signal transduction; Cancer; Mutation; Gene; Cell biology; Genetics; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.03221313954432854,"gpt":0.2671032881778733,"spread":0.2348901486335447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002509685,0.0001646922,0.0002921424,0.0000874321,0.00003094294,0.00001007829,0.0001527098,0.0001442673,0.00003858197],"category_scores_gemma":[0.0001766969,0.0001615858,0.00008929168,0.0002016245,0.0001734663,0.00003410304,0.00005757886,0.00006450158,9.384257e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006806921,"about_ca_system_score_gemma":0.0003314258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00308236,"about_ca_topic_score_gemma":0.001246326,"domain_scores_codex":[0.9987702,0.00003947518,0.0004398572,0.0003987119,0.0001444633,0.0002073089],"domain_scores_gemma":[0.9990863,0.00004074166,0.000310586,0.0002956315,0.0002245452,0.00004216249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004300667,0.0001079345,0.006539505,0.0001781983,0.00007390503,1.353735e-7,0.0001755983,0.00008098376,0.9887422,0.003160867,0.00002044652,0.0004902023],"study_design_scores_gemma":[0.001995996,0.0002085469,0.004331837,0.0001171122,0.00005407662,4.96692e-7,0.00006381623,0.00003780116,0.9877124,0.005268581,0.0000339665,0.0001753932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848129,0.001269854,0.01122064,0.00004827997,0.0002934253,0.0008652631,0.001407157,0.000006073793,0.00007644508],"genre_scores_gemma":[0.9952969,0.0001619858,0.003395832,0.00004366168,0.0001694056,0.0007622954,0.00009217532,0.00002632743,0.00005144294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01048401,"threshold_uncertainty_score":0.6589277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104340741","doi":"10.1158/2159-8290.cd-14-0377","title":"Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions","year":2014,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Crizotinib; Anaplastic lymphoma kinase; ROS1; Medicine; Cancer research; Targeted therapy; CDKN2A; KRAS; Kinase; Bioinformatics; Computational biology; Oncology; Biology; Internal medicine; Adenocarcinoma; Cancer; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.007506143942534965,"gpt":0.2300560095123405,"spread":0.2225498655698055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009158678,0.0002473987,0.0003204448,0.0001399436,0.0002245612,0.00005268317,0.0001204889,0.0001157184,0.0006673234],"category_scores_gemma":[0.0002318247,0.0002161125,0.0002056626,0.0001728588,0.0001358749,0.0005926782,0.00006948545,0.0002367526,0.0002344399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000174435,"about_ca_system_score_gemma":0.0005795994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009844969,"about_ca_topic_score_gemma":0.00002842936,"domain_scores_codex":[0.998488,0.00004792408,0.0003460442,0.0003774163,0.0003294978,0.0004111165],"domain_scores_gemma":[0.9989299,0.00009065311,0.0001313548,0.000420923,0.0001149786,0.0003122013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003780387,0.001364878,0.3245391,0.002699425,0.001004853,0.0005942823,0.0004658587,0.01373685,0.5671147,0.0105366,0.05883445,0.01532868],"study_design_scores_gemma":[0.006849143,0.000359787,0.8230177,0.002452812,0.0008214262,0.00004101978,0.0002808213,0.005139467,0.03594413,0.0004778948,0.1235197,0.001096086],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933873,0.0007084317,0.0009613352,0.0004495122,0.0008249857,0.0003796766,0.00006088327,0.0002041992,0.003023716],"genre_scores_gemma":[0.9928738,0.0001263216,0.00009572827,0.0007243323,0.0008278579,0.0001181289,0.0000560394,0.00005694997,0.005120775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5311705,"threshold_uncertainty_score":0.8812811,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111163869","doi":"10.1158/2159-8290.cd-13-0083","title":"Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities","year":2013,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":448,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"American Association for Cancer Research","keywords":"Isocitrate dehydrogenase; IDH1; IDH2; Biology; Carcinogenesis; Cancer research; Epigenetics; Mutation; Mutant; Myeloid leukemia; Cancer; Enzyme; Genetics; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1344651918348152,"gpt":0.3755100818883636,"spread":0.2410448900535484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002344089,0.0005090143,0.001169477,0.00007620153,0.0001114872,0.0001448579,0.0002867085,0.0005829362,0.00005622995],"category_scores_gemma":[0.00002870149,0.0004398578,0.0007001191,0.00008275312,0.0002269941,0.00003616707,0.0002001257,0.000288304,0.00001801817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005244356,"about_ca_system_score_gemma":0.001722462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001068208,"about_ca_topic_score_gemma":0.00007113739,"domain_scores_codex":[0.9977574,0.000195274,0.0007305592,0.0007683505,0.0001678387,0.0003805367],"domain_scores_gemma":[0.9986932,0.00003718145,0.0004086462,0.0005371997,0.00008811241,0.0002357167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001816557,0.00006505509,8.552611e-7,0.002474916,0.0009845414,0.000005034608,0.00001679058,0.00001677581,0.0001358499,0.00127878,0.01660489,0.9783983],"study_design_scores_gemma":[0.0003453415,0.00007372812,6.075065e-7,0.0009040306,0.001374167,0.00003255974,0.00007152932,0.00002227622,0.00008074952,0.0009554068,0.9955841,0.000555505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004064525,0.9941484,0.00127538,0.00002954365,0.002102791,0.0007345909,0.000903737,0.00001941194,0.0003797483],"genre_scores_gemma":[0.00004111559,0.9861848,0.0002361981,0.000354732,0.002631174,0.000686136,0.001051066,0.0001027092,0.008712037],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9789792,"threshold_uncertainty_score":0.9998053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2540786849","doi":"10.1158/2159-8290.cd-15-1263","title":"The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":444,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen receptor; Cancer research; Neuroendocrine differentiation; Transcription factor; SOX2; Prostate; Enzalutamide; In vivo; Tramp; Biology; Cancer; Medicine; Internal medicine; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03884735603184115,"gpt":0.3067152536351832,"spread":0.2678678976033421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004182369,0.0001801072,0.0002506873,0.00008787528,0.00006717497,0.00004492725,0.0001194731,0.00002964988,0.0003913513],"category_scores_gemma":[0.000009083506,0.00009002392,0.00009461215,0.0001662302,0.0001310887,0.0006343285,0.00002894571,0.0001217334,0.000003801602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003036477,"about_ca_system_score_gemma":0.0001807289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004552068,"about_ca_topic_score_gemma":0.0005077947,"domain_scores_codex":[0.9986002,0.00007854724,0.0002841284,0.0003329414,0.0003298482,0.0003743604],"domain_scores_gemma":[0.9993795,0.00004249573,0.00009792935,0.0002882613,0.00009224627,0.00009957774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00242134,0.0001345411,0.4936869,0.0001179279,0.00009570634,0.00001287035,0.0008145703,0.000006346564,0.464903,0.00001003659,0.0007320687,0.03706475],"study_design_scores_gemma":[0.006601629,0.0004448193,0.5012792,0.0003994041,0.00008558805,0.000003956597,0.0001636377,0.0001630101,0.4865427,0.00006352748,0.0040604,0.0001921357],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884036,0.002449283,0.00001831637,0.007313601,0.0004254202,0.0007560201,0.0005822463,0.00001935449,0.00003214472],"genre_scores_gemma":[0.9826283,0.009840219,0.000003645984,0.0001537153,0.0001295983,0.0002816126,0.00004243617,0.00003044947,0.006890007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03687261,"threshold_uncertainty_score":0.4285023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3024684302","doi":"10.1158/2159-8290.cd-19-1390","title":"The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":433,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; Jewish General Hospital; Institute of Cancer Research","funders":"National Cancer Institute; Susan G. Komen; American Association for Cancer Research; U.S. Department of Defense","keywords":"Cancer research; Breast cancer; KRAS; AKT1; Cancer; Metastatic breast cancer; Cyclin-dependent kinase 4; CHEK1; Kinase; Biology; Estrogen receptor; Cyclin-dependent kinase 6; Medicine; Internal medicine; Cell cycle; Cyclin-dependent kinase; Cell cycle checkpoint; Signal transduction; PI3K/AKT/mTOR pathway; Cyclin-dependent kinase 2; Genetics; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.007344171976413173,"gpt":0.2373030143662544,"spread":0.2299588423898413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008748005,0.000257125,0.0004799792,0.00007493191,0.00007662762,0.00003636763,0.000132461,0.00003769357,0.00002377427],"category_scores_gemma":[0.00002726606,0.0001741142,0.00004850549,0.0004282435,0.0001928748,0.0002920528,0.00009580595,0.0001483926,0.000002744822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003723295,"about_ca_system_score_gemma":0.0002796442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002105172,"about_ca_topic_score_gemma":0.0006537883,"domain_scores_codex":[0.9984089,0.00005672083,0.0003773775,0.0004550187,0.0003660433,0.0003359914],"domain_scores_gemma":[0.9990959,0.0000839889,0.0002099365,0.0002580452,0.0001495941,0.0002025877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06960879,0.0004097669,0.756654,0.0005088196,0.0009771134,0.00004664923,0.006766419,0.0009471795,0.03515172,0.0001375072,0.001320492,0.1274716],"study_design_scores_gemma":[0.006588249,0.0004376443,0.9853914,0.0006679444,0.0001558163,0.000002297294,0.0009065524,0.000007460707,0.004499393,0.00003161699,0.001021821,0.0002897387],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796846,0.01323265,0.00008085025,0.005135528,0.0001349518,0.0009350092,0.0007347307,0.00001979101,0.00004191355],"genre_scores_gemma":[0.9970879,0.001155835,0.0001712114,0.0009760549,0.0001805788,0.0002195237,0.00002200713,0.00005121604,0.0001356793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2287375,"threshold_uncertainty_score":0.7100171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901506506","doi":"10.1158/2159-8290.cd-18-0715","title":"<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Reversion; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Ovarian carcinoma; Mutation; Ovarian cancer; Biology; DNA; Genetics; Medicine; Oncology; Cancer; Polymerase; Gene; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.0169701192130969,"gpt":0.2694381824583575,"spread":0.2524680632452607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472445,0.0002252476,0.0003728094,0.0002000382,0.0001648592,0.00006570087,0.0001433874,0.00008431103,0.00005217451],"category_scores_gemma":[0.00008146624,0.0001898845,0.0000558415,0.0007657855,0.0002669751,0.0004281023,0.00008076851,0.0002067444,0.000008684571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000972196,"about_ca_system_score_gemma":0.0005263136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000740278,"about_ca_topic_score_gemma":0.002304687,"domain_scores_codex":[0.9980623,0.0001216652,0.0004882615,0.0005524191,0.000366818,0.0004085647],"domain_scores_gemma":[0.9990439,0.0001291416,0.0001501086,0.0004625113,0.00007592165,0.0001383763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003877756,0.0004195191,0.6981724,0.0008013789,0.0001148213,0.0003392977,0.01247497,0.0004091617,0.2359655,0.001513962,0.04331727,0.002593971],"study_design_scores_gemma":[0.006049385,0.0002057353,0.9561715,0.002086363,0.00006571733,0.00003249945,0.0007882153,0.0001676429,0.02584973,0.0006838599,0.00752433,0.0003750504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872441,0.001526043,0.0002510815,0.008113303,0.0006780523,0.0009960192,0.0001525597,0.00004105384,0.0009977362],"genre_scores_gemma":[0.9928479,0.0001032612,0.0004297368,0.004604749,0.001021474,0.0003865064,0.00005334121,0.00004086262,0.0005121616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2579991,"threshold_uncertainty_score":0.7743264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2774483419","doi":"10.1158/2159-8290.cd-17-1119","title":"First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"Medicine; Adverse effect; Nausea; Neuroblastoma RAS viral oncogene homolog; Cohort; Response Evaluation Criteria in Solid Tumors; Tolerability; Internal medicine; Cancer; Pharmacokinetics; MEK inhibitor; Oncology; Gastroenterology; MAPK/ERK pathway; Pharmacology; Clinical trial; Phases of clinical research; Kinase; Colorectal cancer; KRAS","retraction":null,"screen_n_in":null,"score":{"opus":0.01034731323142016,"gpt":0.2735128579624377,"spread":0.2631655447310176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001155503,0.0001680101,0.0002547683,0.00005304682,0.00007669353,0.00003957673,0.0001380122,0.00007598925,0.000002243331],"category_scores_gemma":[0.00008071801,0.0001374561,0.00002887987,0.00004927182,0.00007591431,0.00004792871,0.0001128104,0.00007771653,4.521464e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000336349,"about_ca_system_score_gemma":0.00009725372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002037705,"about_ca_topic_score_gemma":0.001968547,"domain_scores_codex":[0.9988205,0.00003368854,0.0003483804,0.0004353083,0.0001553776,0.0002067477],"domain_scores_gemma":[0.9991203,0.000009965534,0.0002842321,0.0004768349,0.00005369795,0.00005497839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01245333,0.002048809,0.6263078,0.0001345477,0.00005113744,0.00003422829,0.001013987,0.0003631028,0.3484898,0.00000810243,0.0001100311,0.008985083],"study_design_scores_gemma":[0.02126631,0.002807692,0.8086477,0.0003999554,0.00001998333,7.107826e-7,0.000317183,0.0001303006,0.1658493,0.00001527935,0.0002779361,0.0002676592],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986793,0.0001352964,0.0000242673,0.00004088403,0.0001575628,0.0006388788,0.0001783482,0.000003671636,0.0001417546],"genre_scores_gemma":[0.99954,0.00006314118,0.00002863531,0.0000210609,0.00008221703,0.00008258001,0.00009075343,0.00001804945,0.00007360236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1826405,"threshold_uncertainty_score":0.5605297,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623263876","doi":"10.1158/2159-8290.cd-17-0419","title":"Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":417,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Cancer research; PARP inhibitor; Germline mutation; Biology; Olaparib; Mutation; Medicine; Genetics; Gene; Poly ADP ribose polymerase; Polymerase","retraction":null,"screen_n_in":null,"score":{"opus":0.02426957560772021,"gpt":0.284101260368508,"spread":0.2598316847607878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003365617,0.000301475,0.0004984154,0.0001236893,0.0006373344,0.0003075854,0.0002881013,0.0001142705,0.00004657413],"category_scores_gemma":[0.000164466,0.0002299997,0.0000663863,0.0002512242,0.0003427292,0.0007408127,0.0000896393,0.0003075131,0.000006564567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007709692,"about_ca_system_score_gemma":0.000744751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008509278,"about_ca_topic_score_gemma":0.008837909,"domain_scores_codex":[0.9979726,0.0001051143,0.0004280268,0.000558418,0.0004508699,0.0004849767],"domain_scores_gemma":[0.9982985,0.0001851209,0.0003466656,0.0008855669,0.00008295693,0.0002012311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002780089,0.0004678702,0.9278662,0.0005917272,0.0005615443,0.0003755929,0.008486041,0.0006873509,0.02768918,0.003430985,0.02482936,0.002234087],"study_design_scores_gemma":[0.007243521,0.000177793,0.9713956,0.002036946,0.0001592157,0.00002035807,0.000464333,0.00006109697,0.011943,0.0009909102,0.005070318,0.0004369675],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785051,0.001589546,0.000133726,0.01638944,0.0006201538,0.0009476041,0.0002634716,0.00006098675,0.001489958],"genre_scores_gemma":[0.9941635,0.0001356488,0.0003425545,0.001900051,0.0005467574,0.0006697426,0.00004269572,0.00006523703,0.002133803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04352937,"threshold_uncertainty_score":0.9379116,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038264590","doi":"10.1158/2159-8290.cd-12-0386","title":"Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma","year":2012,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":373,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Wellcome Trust","keywords":"Vemurafenib; Dasatinib; Cancer research; Src family kinase; Melanoma; Tyrosine kinase; EGFR inhibitors; Metastasis; Epidermal growth factor receptor; Gefitinib; Medicine; Signal transduction; Kinase; Proto-oncogene tyrosine-protein kinase Src; Biology; Cancer; Oncogene; Internal medicine; Cell cycle; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02031716774709106,"gpt":0.2606265288370754,"spread":0.2403093610899843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002595705,0.0002573769,0.0002598318,0.00007003294,0.00008907971,0.00006155108,0.0001791152,0.0001873787,0.00006613028],"category_scores_gemma":[0.000103313,0.0002254572,0.0001068913,0.0001787958,0.00006801676,0.00005876386,0.0001408245,0.0001563969,0.00001896143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001032969,"about_ca_system_score_gemma":0.0002321607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000917827,"about_ca_topic_score_gemma":0.0004222788,"domain_scores_codex":[0.9983709,0.00008411908,0.0003471811,0.0004277549,0.0001860206,0.0005840473],"domain_scores_gemma":[0.9993317,0.00003689135,0.0001334766,0.0003128461,0.00004004668,0.0001450062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003980209,0.00008954854,0.03275634,0.0001039116,0.00002927694,0.00001275457,0.0002273161,0.00002028233,0.9587085,0.0002636302,0.006372783,0.001017661],"study_design_scores_gemma":[0.00114032,0.0001350782,0.008789263,0.0003406414,0.0000205195,0.000004339799,0.0005304193,0.000003086883,0.9029054,0.00004964646,0.08553758,0.0005437054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847311,0.01104988,0.0002406629,0.00009265142,0.0008911021,0.0002243018,0.0001373397,0.00002018794,0.002612828],"genre_scores_gemma":[0.9927188,0.0004758967,0.0004958298,0.0005826821,0.001759268,0.0001088822,0.0001104026,0.00004734872,0.003700891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07916479,"threshold_uncertainty_score":0.9193876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2232697670","doi":"10.1158/2159-8290.cd-15-0402","title":"Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Mental Health; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Howard Hughes Medical Institute","keywords":"Pancreatic cancer; CDKN2A; Biology; Genetics; Cancer; Germline mutation; Genetic heterogeneity; Germline; Exome sequencing; PALB2; Genome; Hereditary pancreatitis; Gene; Mutation; Phenotype; Trypsinogen","retraction":null,"screen_n_in":null,"score":{"opus":0.08514090614727875,"gpt":0.3590900383823112,"spread":0.2739491322350324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002796589,0.0001637096,0.0005353286,0.00005958372,0.00007585019,0.00002007247,0.0001872148,0.000088237,0.00007725334],"category_scores_gemma":[0.000124852,0.000102537,0.0001142824,0.0002167154,0.0003573798,0.0001093751,0.00009110611,0.0001826728,0.00002115352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005326794,"about_ca_system_score_gemma":0.002178017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004288226,"about_ca_topic_score_gemma":0.0007591014,"domain_scores_codex":[0.9985402,0.0001007298,0.0003265696,0.0002628609,0.0004098995,0.0003597589],"domain_scores_gemma":[0.9989631,0.0001065762,0.0001196981,0.0004372379,0.0001946737,0.0001787754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003862702,0.00006434073,0.9463858,0.0002303158,0.0003617808,0.00003477831,0.0008862171,0.0005685876,0.04868795,0.00006031928,0.001212115,0.001121548],"study_design_scores_gemma":[0.002575938,0.0004565829,0.9834374,0.0003125572,0.0009484983,0.00005915962,0.001134776,0.001245575,0.004939371,0.0003865494,0.004259752,0.0002438765],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813044,0.01492557,0.0003202883,0.0009672171,0.0002485166,0.0004721952,0.000131244,0.00001882128,0.001611712],"genre_scores_gemma":[0.9940406,0.00186051,0.0002578626,0.0005910537,0.0005159465,0.0002618489,0.00001647002,0.00002462915,0.002431086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04374857,"threshold_uncertainty_score":0.6482543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2987822998","doi":"10.1158/2159-8290.cd-19-0980","title":"Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital; Spinal Cord Injury BC; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Immunotherapy; Medicine; Adenosine; Immune system; Adenosine receptor; Cancer immunotherapy; Immune checkpoint; Cancer research; Tumor microenvironment; Adenosinergic; Immunology; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01063077721363765,"gpt":0.283419011275283,"spread":0.2727882340616453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004761104,0.0002495085,0.0002301799,0.00003411797,0.00007749776,0.00005234207,0.0001936147,0.0001602395,0.0006431202],"category_scores_gemma":[0.000003999156,0.0002114293,0.0001619255,0.00006027126,0.00003921143,0.00002750655,0.00002863348,0.0000530834,0.00002175109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009660257,"about_ca_system_score_gemma":0.0003625743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005711819,"about_ca_topic_score_gemma":0.00003944534,"domain_scores_codex":[0.9988587,0.00003108013,0.0001920741,0.0004884488,0.0001065084,0.0003231925],"domain_scores_gemma":[0.9993273,0.00001639995,0.0001193782,0.0003931072,0.00006032513,0.00008346775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000849343,0.0001666735,0.003412192,0.00002906847,0.0001562366,0.000001001123,0.0001067687,0.0005598055,0.9787319,0.00002069754,0.01336316,0.002603187],"study_design_scores_gemma":[0.00183176,0.001037928,0.0002444234,0.00002995161,0.00003878901,0.000001501804,0.00006850996,0.00001923873,0.6401092,0.00002053933,0.3563247,0.0002735003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9659047,0.03177043,0.0002546253,0.0002029668,0.0006235345,0.0004228791,0.0002843134,0.00001627531,0.0005203412],"genre_scores_gemma":[0.9524963,0.007228506,0.000143172,0.0006784621,0.001983244,0.0003595623,0.0004620442,0.00007378402,0.03657491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3429615,"threshold_uncertainty_score":0.8621835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4307493936","doi":"10.1158/2159-8290.cd-22-0523","title":"Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity","year":2022,"lang":"en","type":"letter","venue":"Cancer Discovery","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":325,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Departament d'Empresa i Coneixement, Generalitat de Catalunya; Instituto de Salud Carlos III; Natural Sciences and Engineering Research Council of Canada; Fondation Charles-Bruneau; Centre de recherche du CHU Sainte-Justine; Fonds de Recherche du Québec - Santé; Harald och Greta Jeanssons Stiftelse; Banco Bilbao Vizcaya Argentaria; Vetenskapsrådet; Fundación Científica Asociación Española Contra el Cáncer; Ministerio de Ciencia e Innovación; Generalitat de Catalunya; Cancerfonden; Agència de Gestió d'Ajuts Universitaris i de Recerca; Canadian Institutes of Health Research; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; Fundación BBVA; Karolinska Institutet; Loo och Hans Ostermans Stiftelse för Medicinsk Forskning; Institute for Research in Biomedicine; Institució Catalana de Recerca i Estudis Avançats; Canada Foundation for Innovation","keywords":"Immune system; Senescence; CD8; Cytotoxic T cell; Biology; Antigen presentation; Acquired immune system; Cancer cell; MHC class I; Cell biology; Antigen; Context (archaeology); Cross-presentation; Immunogenic cell death; Immunology; T cell; Cancer; Immunotherapy; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.0217868729255454,"gpt":0.2629831845038303,"spread":0.2411963115782849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001872128,0.0006275683,0.0009570837,0.0002373291,0.0003654054,0.0001598993,0.0004328171,0.0004220944,0.002002087],"category_scores_gemma":[0.00004781376,0.0005811608,0.000315011,0.0004057514,0.000401332,0.0003523547,0.0003837854,0.002578583,0.00003214363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003750702,"about_ca_system_score_gemma":0.0009045764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001591563,"about_ca_topic_score_gemma":0.00001441855,"domain_scores_codex":[0.9969314,0.0001469924,0.0005033276,0.0009483254,0.0007397335,0.000730174],"domain_scores_gemma":[0.998163,0.0001046981,0.0002946951,0.001211546,0.0001002785,0.0001257485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003883451,0.0001794911,0.01651642,0.003840164,0.0006863598,0.003524073,0.001338967,7.465394e-7,0.07114872,0.00001340351,0.8986381,0.003725219],"study_design_scores_gemma":[0.001170582,0.000346717,0.007038543,0.001017447,0.0006690962,0.00033358,0.0002495177,0.0000219688,0.02666768,0.00006239832,0.9613678,0.001054615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.5909688,0.08923743,0.00009543246,0.3118021,0.003135536,0.001872538,0.001703184,0.0002644819,0.0009204007],"genre_scores_gemma":[0.2258338,0.02447301,0.0001455638,0.701992,0.005776168,0.0004917547,0.00193376,0.0003612693,0.03899257],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.3901899,"threshold_uncertainty_score":0.9997225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097709883","doi":"10.1158/2159-8290.cd-11-0347","title":"A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":323,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"KRAS; MAPK/ERK pathway; Cancer research; MEK inhibitor; Trametinib; Protein kinase B; PI3K/AKT/mTOR pathway; Effector; Selumetinib; Pancreatic Intraepithelial Neoplasia; Biology; Kinase; Medicine; Signal transduction; Cancer; Cell biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04176939521235211,"gpt":0.3402665793685451,"spread":0.298497184156193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004316459,0.0001187207,0.0004278658,0.00007249529,0.00005360846,0.00001170448,0.0001323191,0.00007731745,0.0001035437],"category_scores_gemma":[0.0001198752,0.00007775256,0.0001251257,0.0001750121,0.0001256983,0.0001681954,0.00002843522,0.0001283946,0.000003130931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001544082,"about_ca_system_score_gemma":0.0003851876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008521132,"about_ca_topic_score_gemma":0.0000374509,"domain_scores_codex":[0.9987093,0.00008691525,0.0002686475,0.0001562446,0.0002429898,0.0005358543],"domain_scores_gemma":[0.9991859,0.0003603277,0.00007654723,0.0002342742,0.00004435372,0.00009859728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000523105,0.0001924544,0.9846884,0.0002272871,0.0001313922,0.000007316829,0.003756177,0.00001246393,0.009211253,0.0004015237,0.0005067154,0.000341888],"study_design_scores_gemma":[0.001646629,0.0001964111,0.989784,0.0001572421,0.0004516989,0.0000281517,0.004417819,0.0002683759,0.002545611,0.0001618836,0.0002482732,0.00009390134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800519,0.01745039,0.0003615706,0.0004869006,0.0001271629,0.000764307,0.00004333107,0.000007004334,0.0007074495],"genre_scores_gemma":[0.9974997,0.0003773815,0.000353209,0.0002798055,0.0006229749,0.0003739077,0.00001890086,0.00001724048,0.0004568583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01744784,"threshold_uncertainty_score":0.3170658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099505694","doi":"10.1158/2159-8290.cd-11-0224","title":"Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Small hairpin RNA; Biology; Breast cancer; Ovarian cancer; Pancreatic cancer; Cancer; Gene; Functional genomics; Computational biology; Genomics; Genome; Synthetic lethality; Bioinformatics; Cancer research; Genetics; Mutant; RNA","retraction":null,"screen_n_in":null,"score":{"opus":0.008949994002293536,"gpt":0.2285446214838701,"spread":0.2195946274815765,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005234797,0.000156028,0.0001694258,0.00003665316,0.00003723784,0.00003972229,0.0001154325,0.00009834136,0.0000935014],"category_scores_gemma":[0.000004950023,0.000152309,0.00004595868,0.0000647735,0.00009119071,0.00001156682,0.0001174265,0.00006466165,0.000002234701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003877536,"about_ca_system_score_gemma":0.0002308771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003778163,"about_ca_topic_score_gemma":0.001419513,"domain_scores_codex":[0.9991273,0.00001940741,0.0001714933,0.0003634247,0.00006737207,0.0002509686],"domain_scores_gemma":[0.9995961,0.000007653523,0.00006474574,0.0002263068,0.00002867507,0.00007655506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003640508,0.0001040043,0.1526318,0.00006195894,0.00009772743,0.00001842545,0.0002500789,0.0001136557,0.8396798,0.0003205767,0.002271526,0.004086387],"study_design_scores_gemma":[0.001053169,0.00007191714,0.149583,0.0000628763,0.00006931294,0.00001417071,0.00008458705,0.00004885441,0.8455074,0.0002747878,0.002846377,0.0003836308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922472,0.005619449,0.000227254,0.0001009807,0.0004217491,0.0001895343,0.000505281,0.000005316276,0.0006831904],"genre_scores_gemma":[0.9872788,0.01091893,0.0002521872,0.0003417801,0.0005537081,0.000159217,0.00004782885,0.00002792422,0.0004196475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005827512,"threshold_uncertainty_score":0.6210979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2912552280","doi":"10.1158/2159-8290.cd-18-1090","title":"Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Deutsche Krebshilfe; Terry Fox Research Institute; Michael Smith Health Research BC; Uehara Memorial Foundation","keywords":"Immune system; Biology; Major histocompatibility complex; Computational biology; Immune recognition; Genetics; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.009030182547025933,"gpt":0.2529846919510217,"spread":0.2439545094039958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008033758,0.00009694447,0.0001193349,0.0000352082,0.00003363973,0.0000331167,0.00005877608,0.00007638169,0.0000153408],"category_scores_gemma":[0.00001908145,0.00009742741,0.00005818033,0.00005189003,0.00003183671,0.00001442851,0.00003083679,0.00002585822,0.000002082905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001011841,"about_ca_system_score_gemma":0.00006214715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000199973,"about_ca_topic_score_gemma":0.000008603506,"domain_scores_codex":[0.9993339,0.00002589671,0.0002005236,0.0002376507,0.00007819568,0.0001239043],"domain_scores_gemma":[0.9995903,0.000009549541,0.0001343847,0.0001588658,0.00008644004,0.00002050863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004876369,0.0000167567,0.0027937,0.0001024353,0.00002313887,1.410348e-7,0.00004455199,0.000124689,0.9909286,0.00002966339,6.389188e-7,0.005886888],"study_design_scores_gemma":[0.0002988363,0.0002255408,0.0188217,0.00003918079,0.00003046201,6.651646e-7,0.00003559205,0.00008687624,0.9790955,0.0009761174,0.0002623566,0.0001272393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611999,0.008233604,0.02980913,0.00002791312,0.0002461327,0.0003354965,0.00005962685,0.000003520094,0.00008463427],"genre_scores_gemma":[0.9972973,0.001824971,0.0001622772,0.00005308132,0.00006054502,0.00005762552,0.0002954188,0.00001929859,0.0002294832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03609736,"threshold_uncertainty_score":0.3972974,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144174481","doi":"10.1158/2159-8290.cd-14-0341","title":"Targeting Cancer-Derived Adenosine:New Therapeutic Approaches","year":2014,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; American Association for Cancer Research","keywords":"Adenosinergic; Adenosine; Tumor microenvironment; Medicine; Cancer; Adenosine receptor; Disease; Clinical trial; Immune system; Immunotherapy; Cancer research; Immunology; Bioinformatics; Biology; Receptor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07511833834698431,"gpt":0.3278120246382449,"spread":0.2526936862912605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001354657,0.0006272061,0.001168111,0.00006881456,0.0001107562,0.0001195008,0.0005324585,0.0004900015,0.000108033],"category_scores_gemma":[0.00002678647,0.0005043931,0.0005548511,0.0001702296,0.00008131444,0.0000123444,0.0001998811,0.0003187855,0.00001637968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008861299,"about_ca_system_score_gemma":0.001131757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001985807,"about_ca_topic_score_gemma":0.00001260693,"domain_scores_codex":[0.9978132,0.0001430116,0.0005248912,0.0008387985,0.0001918595,0.0004882794],"domain_scores_gemma":[0.9988303,0.00003566143,0.0004454614,0.0005137913,0.00003655161,0.0001382299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004948245,0.00006439388,0.00007654959,0.01160874,0.001674783,0.00000794332,0.00005743083,0.0005696786,0.001478566,0.0001747536,0.1014896,0.8827481],"study_design_scores_gemma":[0.0002234593,0.00005018323,0.000002388186,0.00298303,0.0007648586,0.000007661994,0.00001643843,0.0000114563,0.0004999695,0.00002030166,0.9947448,0.000675481],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005111181,0.9937552,0.00450692,0.00007744477,0.00071236,0.0004453155,0.0001039009,0.00002572342,0.0003219765],"genre_scores_gemma":[0.0004909515,0.9868929,0.00009040524,0.0002749526,0.005660383,0.0003549937,0.0006811249,0.0001509491,0.005403349],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8932551,"threshold_uncertainty_score":0.9997408,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137273906","doi":"10.1158/2159-8290.cd-14-1156","title":"Biallelic Mutations in <i>BRCA1</i> Cause a New Fanconi Anemia Subtype","year":2014,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":284,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; McGill University and Génome Québec Innovation Centre; McGill Genome Centre; McGill University; Children's Hospital of Eastern Ontario","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Canadian Institutes of Health Research; National Cancer Institute; University of Pennsylvania","keywords":"Fanconi anemia; Genetics; BRCA2 Protein; Biology; DNA repair; Cancer research; Mutation; Cancer; Genetic counseling; Bloom syndrome; Gene; Germline mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.01585569712067575,"gpt":0.2841776329413845,"spread":0.2683219358207088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009140642,0.0001549781,0.0001406506,0.00006625445,0.00005241921,0.00005476067,0.0001950723,0.0001258433,0.00006726245],"category_scores_gemma":[0.00007642961,0.0001627015,0.0000649349,0.0002169782,0.00007616325,0.00001749447,0.00006743524,0.0001053353,0.00002563033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001470464,"about_ca_system_score_gemma":0.0008365982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005663485,"about_ca_topic_score_gemma":0.004973957,"domain_scores_codex":[0.998971,0.00004587452,0.0002107437,0.0003987289,0.0001129482,0.0002606982],"domain_scores_gemma":[0.9993756,0.0000188104,0.00007592052,0.0004035716,0.00004499,0.00008110077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003369804,0.0001923253,0.1068613,0.0001373524,0.0002416335,0.00001597971,0.001169557,0.03561445,0.6604102,0.001997836,0.1517265,0.04129593],"study_design_scores_gemma":[0.005606587,0.0004165847,0.1096796,0.0001794328,0.0001636939,0.00003270488,0.0004274202,0.0005093192,0.3325325,0.003252582,0.5456368,0.001562725],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873391,0.002589184,0.005179536,0.0009931182,0.000786812,0.0002161962,0.00005115006,0.00002000335,0.00282493],"genre_scores_gemma":[0.9922001,0.0005114602,0.0004270944,0.001281565,0.0008204054,0.0001076088,0.0001362323,0.00003596509,0.004479503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3939103,"threshold_uncertainty_score":0.6634775,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3115597636","doi":"10.1158/2159-8290.cd-20-0387","title":"Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":280,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; NIH Office of the Director; University of California, San Diego; Weill Cornell Medical College; Genentech; National Institutes of Health; Celgene; Queen's University; Queen's University Belfast; Academy of Medical Sciences; Cancer Research UK; Ludwig Institute for Cancer Research; Swim Across America; Parker Institute for Cancer Immunotherapy; Robertson Foundation; Francis Crick Institute; Burroughs Wellcome Fund; Prostate Cancer Foundation; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation; Sanofi; AstraZeneca; Pfizer; Public Health Agency; Friends of the Cancer Centre; GlaxoSmithKline","keywords":"Immune system; Metastasis; Innate immune system; Cancer research; Biology; Immunotherapy; Extracellular; Inflammation; Cancer cell; Cancer immunotherapy; CCL18; Cancer; Cell biology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.02133506582022331,"gpt":0.24298850477369,"spread":0.2216534389534667,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000807246,0.0001884472,0.0003624243,0.0000419507,0.0001144136,0.00004745183,0.0001704157,0.0001290373,0.00194297],"category_scores_gemma":[0.00006950201,0.000156054,0.0001401679,0.00009806509,0.0001504057,0.0002701719,0.0001391349,0.0002204669,0.000269404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003117535,"about_ca_system_score_gemma":0.00005636844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005399713,"about_ca_topic_score_gemma":0.00001116825,"domain_scores_codex":[0.9989323,0.000184375,0.0002566306,0.0003493149,0.00003494417,0.0002424409],"domain_scores_gemma":[0.9995019,0.000134241,0.00009121844,0.0002198101,0.00002248164,0.00003037188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008146459,0.00003016064,0.0005607625,0.00001583928,0.0004235373,0.000006982888,0.0006164503,0.000007396586,0.9837622,0.0001320922,0.001573835,0.01205609],"study_design_scores_gemma":[0.001123302,0.0001498084,0.003610374,0.00005327309,0.0001992755,0.000006144569,0.0004973307,0.0000354966,0.8976777,0.00005792941,0.09634247,0.0002469309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8603845,0.1365516,0.000474347,0.001514124,0.0004375596,0.0001322388,0.0001936138,0.00004599657,0.0002659543],"genre_scores_gemma":[0.9937161,0.002348278,0.00002350252,0.0005670046,0.0000597061,0.00003303708,0.0001110283,0.00002102632,0.003120381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1342033,"threshold_uncertainty_score":0.9989694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3014806119","doi":"10.1158/2159-8290.cd-19-1030","title":"Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"CRIS Cancer Foundation; Deutsche Kinderkrebsstiftung; NIHR Great Ormond Street Hospital Biomedical Research Centre; Deutsche Krebshilfe; Brain Tumour Charity; Medical Research Council; CHILDREN with CANCER UK; Australian Lions Childhood Cancer Research Foundation; Cure Brain Cancer Foundation; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; National Cancer Institute; Ira Sohn Research Conference Foundation; Making Headway Foundation; National Institutes of Health; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; Marie-Josée and Henry R. Kravis Center for Molecular Oncology; American Lebanese Syrian Associated Charities; Lions Clubs International Foundation; Friedberg Charitable Foundation; Cancer Research UK; Children's Hospital Foundation","keywords":"Gene; Biology; Glioma; Cancer research; Oncology; Bioinformatics; Genetics; Medicine; Computational biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02362995440538189,"gpt":0.2565559089169627,"spread":0.2329259545115808,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004448017,0.0002986702,0.0006683957,0.00006355227,0.000148379,0.00009860045,0.00009121331,0.00008370444,0.0001386084],"category_scores_gemma":[0.00003627123,0.0002264173,0.0001651349,0.0002329407,0.00007774463,0.0003285554,0.0001196786,0.0001450174,0.00001938559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001034317,"about_ca_system_score_gemma":0.0001061895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00153455,"about_ca_topic_score_gemma":0.00006236588,"domain_scores_codex":[0.9985377,0.00001937269,0.0003064764,0.0004919447,0.0002614045,0.0003830949],"domain_scores_gemma":[0.9990928,0.00009039543,0.0001200632,0.0002758648,0.0000440248,0.0003769032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002178552,0.0006504989,0.4848256,0.0001080979,0.0003750373,0.00007144603,0.0001737158,0.00001723654,0.5102604,0.00008094369,0.002875566,0.0003435432],"study_design_scores_gemma":[0.02586779,0.0004812121,0.629245,0.0001979471,0.0009726514,0.00003296392,0.0002217512,0.0009511136,0.2702272,0.00003892282,0.07096621,0.0007972777],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808557,0.007970309,0.0005184956,0.00810943,0.0002382058,0.0008088992,0.001384754,0.00008069698,0.00003352591],"genre_scores_gemma":[0.9931841,0.00181995,0.0008240379,0.002828477,0.0001791421,0.0003953348,0.0004161904,0.00004608219,0.0003067182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2400333,"threshold_uncertainty_score":0.9233028,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2531449940","doi":"10.1158/2159-8290.cd-16-0975","title":"<i>CREBBP</i> Inactivation Promotes the Development of HDAC3-Dependent Lymphomas","year":2016,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":272,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"HDAC3; Computational biology; Biology; Cancer research; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01506601086359499,"gpt":0.2797760310984957,"spread":0.2647100202349008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001845625,0.00009921338,0.00009056171,0.00002662498,0.00007949388,0.00001527436,0.000195394,0.00006449322,0.00003041437],"category_scores_gemma":[0.00007350939,0.00005553406,0.00004729638,0.00007009748,0.0001213825,0.00001277995,0.0001255206,0.00003626384,0.000009397793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001365891,"about_ca_system_score_gemma":0.0005729639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003800085,"about_ca_topic_score_gemma":0.0001500317,"domain_scores_codex":[0.9991124,0.00004495944,0.000194734,0.0002339125,0.0002317596,0.0001822733],"domain_scores_gemma":[0.9994715,0.00002152775,0.00008701862,0.0003005661,0.00008407013,0.0000353185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007640629,0.00003925152,0.00141874,0.00001851432,0.00003913277,4.270174e-7,0.0001303039,0.00000323196,0.98182,0.00005291582,0.001462348,0.01493866],"study_design_scores_gemma":[0.0003700622,0.00004309887,0.00228202,0.00005620471,0.000004593697,0.00000163946,0.00006106192,8.492322e-7,0.9781311,0.00002575182,0.01892876,0.000094881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956881,0.0005833649,0.001947135,0.0003894702,0.0001396354,0.0001906048,0.00002987427,0.000005340955,0.001026522],"genre_scores_gemma":[0.9955003,0.0001109187,0.0001130182,0.00004979976,0.0001722622,0.0001107936,0.00001450943,0.00001665774,0.003911693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01746641,"threshold_uncertainty_score":0.2264613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2608211931","doi":"10.1158/2159-8290.cd-17-0146","title":"Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Cancer Research UK","keywords":"Reversion; DNA; Mutation; Poly ADP ribose polymerase; DNA damage; Biology; Chemistry; Cancer research; Genetics; Gene; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.02755752012958285,"gpt":0.3162239602348135,"spread":0.2886664401052306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002485464,0.0001713325,0.0005752082,0.0002321127,0.000230328,0.00004950887,0.0002493658,0.00007753434,0.00004534827],"category_scores_gemma":[0.0002807908,0.0001567308,0.0002513461,0.0005386661,0.0002733908,0.0003900464,0.0000841844,0.000113076,0.000001005675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003208707,"about_ca_system_score_gemma":0.0002316113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004392278,"about_ca_topic_score_gemma":0.002609615,"domain_scores_codex":[0.998303,0.00005628474,0.0004837977,0.0003669179,0.000571645,0.0002183551],"domain_scores_gemma":[0.9976384,0.0001274043,0.0008169358,0.0009498405,0.0003614076,0.0001060183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007056085,0.0002303945,0.6701787,0.0002517239,0.001906912,0.00001799414,0.0009615931,0.003982125,0.3199809,0.00002710793,0.001608079,0.0001488028],"study_design_scores_gemma":[0.002123624,0.00007463023,0.5263759,0.0009930313,0.001408378,5.661006e-7,0.0002174504,0.0001610931,0.4683644,0.00004791787,0.00005931078,0.0001736372],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966148,0.0003975249,0.0006034038,0.0004982576,0.0001968379,0.0003202159,0.0007331306,0.00002052893,0.0006153294],"genre_scores_gemma":[0.9986113,0.00005689038,0.0002806824,0.0001542546,0.0000724999,0.00005871102,0.00008637359,0.00002366764,0.0006556358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1483835,"threshold_uncertainty_score":0.6391298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2332535881","doi":"10.1158/2159-8290.cd-15-0944","title":"Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":231,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Cancer; Cancer research; Lymphocyte; Medicine; Computational biology; Immunology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02723035739404087,"gpt":0.2963873336173062,"spread":0.2691569762232654,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008699331,0.0001570847,0.0002796648,0.00007727391,0.00007319965,0.00001304142,0.0001162281,0.00010836,0.002612994],"category_scores_gemma":[0.00002858444,0.0001010457,0.000195945,0.00006837067,0.00008981414,0.0004371544,0.00003110697,0.00005540265,0.00001372243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002394614,"about_ca_system_score_gemma":0.0003774462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001286582,"about_ca_topic_score_gemma":0.0000363413,"domain_scores_codex":[0.9991314,0.00005941954,0.0003067281,0.0002308253,0.00003084605,0.0002407144],"domain_scores_gemma":[0.9993665,0.0000873715,0.0002366785,0.0002150097,0.00007917987,0.00001524982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001849968,0.00004565022,0.0004278315,0.00002457672,0.000277139,1.498913e-7,0.0001059248,0.00006115087,0.9581072,0.00009230592,0.01679829,0.0222098],"study_design_scores_gemma":[0.002278368,0.00008873692,0.0002485887,0.0001947681,0.00004194702,0.000003693638,0.0000555545,0.000008191689,0.6871073,0.00007678856,0.3097858,0.0001103058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8269235,0.07721984,0.07509001,0.0009105686,0.01816848,0.0007605153,0.0005979949,0.000118657,0.000210461],"genre_scores_gemma":[0.9401964,0.006169511,0.0004242743,0.0004222395,0.0002778242,0.0001776142,0.00008282069,0.00008140905,0.0521679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2929874,"threshold_uncertainty_score":0.9982988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2258535515","doi":"10.1158/2159-8290.cd-15-1336","title":"Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Melanoma; Precision medicine; Medicine; Personalized medicine; Liquid biopsy; Targeted therapy; Exome sequencing; Biopsy; Oncology; Cancer research; Exome; Internal medicine; Mutation; Bioinformatics; Pathology; Cancer; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02417063816839317,"gpt":0.2713803003633998,"spread":0.2472096621950067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008082065,0.00009050785,0.0001503305,0.00003428381,0.00001489069,0.000004444446,0.00006116495,0.0000705493,0.000002355235],"category_scores_gemma":[0.00004458859,0.00007667702,0.00002698636,0.00005196734,0.0001109603,0.000007494504,0.00003572911,0.00002439009,1.99477e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003189113,"about_ca_system_score_gemma":0.0001428762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003385498,"about_ca_topic_score_gemma":0.0001582525,"domain_scores_codex":[0.9994183,0.0000189713,0.0001614086,0.0002093866,0.00007164486,0.0001202987],"domain_scores_gemma":[0.9996396,0.000008242212,0.00008964619,0.0001429858,0.00006213395,0.00005744465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005064385,0.00001491369,0.003333046,0.00005338629,0.00001949949,6.171129e-7,0.0005866466,0.00001992973,0.9925637,0.0002903626,0.0009526859,0.00165874],"study_design_scores_gemma":[0.002882955,0.001888289,0.001234208,0.00007951388,0.00003277088,0.000007200847,0.001559996,0.0001219175,0.9415138,0.0001972529,0.05026153,0.0002205998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901218,0.005998166,0.002987881,0.0001425803,0.0001317162,0.0002939916,0.0000764054,0.000003802369,0.0002435962],"genre_scores_gemma":[0.9988398,0.0002691273,0.0001553605,0.0001669527,0.0001480604,0.0001753902,0.0001382192,0.00001126427,0.00009584367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05104997,"threshold_uncertainty_score":0.3126798,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2598954950","doi":"10.1158/2159-8290.cd-16-0795","title":"A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic <i>BRAF</i> -Mutant Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Seventh Framework Programme; Deutschen Konsortium für Translationale Krebsforschung","keywords":"Cetuximab; Medicine; Colorectal cancer; Tolerability; Oncology; Internal medicine; Concomitant; Cancer; Population; Pharmacology; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.04112415896288415,"gpt":0.3710117573194283,"spread":0.3298875983565441,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009970178,0.000265153,0.0007958057,0.00009761125,0.0001864795,0.00007939091,0.00009978341,0.0000348672,0.00004774456],"category_scores_gemma":[0.00003839607,0.0001618063,0.0000467859,0.0001526811,0.0002298298,0.0004569719,0.00008642351,0.0001336063,4.841176e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002702761,"about_ca_system_score_gemma":0.0004382173,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008912066,"about_ca_topic_score_gemma":0.0599536,"domain_scores_codex":[0.9986125,0.00003680564,0.0003281555,0.0004341177,0.0003235432,0.0002648428],"domain_scores_gemma":[0.9991553,0.00004498741,0.0003008569,0.0003125038,0.00009697121,0.0000893757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02343177,0.00482821,0.9215629,0.0002885712,0.001055434,0.0003002273,0.009085322,0.00005140711,0.0035766,0.00001115934,0.000083102,0.0357253],"study_design_scores_gemma":[0.07190936,0.01576112,0.8944662,0.001007642,0.001650003,0.00004241306,0.008232155,0.0006596145,0.005633645,0.00002621269,0.0001677336,0.00044392],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955402,0.001815877,0.00001411925,0.0002531307,0.000198815,0.00156089,0.0001403051,0.00001616939,0.0004604722],"genre_scores_gemma":[0.9977182,0.0009759439,0.00004461938,0.00007102053,0.00008123739,0.0007343558,0.000007330464,0.00002949066,0.0003377775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05104153,"threshold_uncertainty_score":0.9976877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4206012887","doi":"10.1158/2159-8290.cd-21-0808","title":"A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota","year":2022,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":227,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Clinical Research Institute; Centre hospitalier de l'Université Laval; Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Québec; McGill University; Centre hospitalier universitaire de Québec; McGill University Health Centre; Université Laval; Université de Montréal","funders":"Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"Polyphenol; Gut flora; Biology; Microbiology; Microbiome; Resistance (ecology); Computational biology; Biochemistry; Bioinformatics; Ecology; Antioxidant","retraction":null,"screen_n_in":null,"score":{"opus":0.01351669931918685,"gpt":0.274944839005784,"spread":0.2614281396865972,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0001304946,0.0002198091,0.0002739135,0.0000673662,0.001411504,0.0001356992,0.0002477723,0.00003887534,0.00003796421],"category_scores_gemma":[0.00001518012,0.0001755942,0.00008737271,0.0003188782,0.0000953416,0.0003835425,0.0001418964,0.0004688794,0.00000488942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004305553,"about_ca_system_score_gemma":0.00008459383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006748218,"about_ca_topic_score_gemma":0.000245329,"domain_scores_codex":[0.9984582,0.0001959853,0.0001679383,0.0004563095,0.000271366,0.0004501842],"domain_scores_gemma":[0.9991579,0.0002173511,0.0001392714,0.0004069951,0.00002275192,0.00005571842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003749452,0.0006947757,0.00779372,0.001333161,0.0002121982,0.0001244153,0.003134594,0.0001941168,0.9046987,0.0060148,0.05998348,0.01206658],"study_design_scores_gemma":[0.003671446,0.000566539,0.8240011,0.001679102,0.0002064058,0.00006100418,0.0004340813,0.0001802674,0.1218804,0.002768533,0.04327616,0.001274946],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786622,0.008214639,0.00001149106,0.008872776,0.002672009,0.0006098479,0.0003114582,0.00005113766,0.0005944349],"genre_scores_gemma":[0.9944384,0.0002021539,0.0000196445,0.004236467,0.0001998636,0.0001681796,0.00001329451,0.00003452903,0.0006874374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8162074,"threshold_uncertainty_score":0.9998885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2994693426","doi":"10.1158/2159-8290.cd-19-0680","title":"Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; Spinal Cord Injury BC; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"Terry Fox Research Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; European Hematology Association; Uehara Memorial Foundation; Genome Canada; Kanae Foundation for the Promotion of Medical Science; Michael Smith Health Research BC; Genome British Columbia","keywords":"Transcriptome; Lymphoma; Tumor microenvironment; Cancer research; Disease; Biology; Cell; Computational biology; Hodgkin lymphoma; Tumor cells; Medicine; Immunology; Gene; Pathology; Genetics; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.01334778084631682,"gpt":0.2363575779946373,"spread":0.2230097971483204,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598681,0.0002563798,0.0006096935,0.0001924715,0.00003383124,0.00004008054,0.000176108,0.00004660996,0.0002078827],"category_scores_gemma":[0.000006197748,0.0001733081,0.0004408721,0.0005190435,0.00008214873,0.000151647,0.00002886254,0.00006574681,0.00005500867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005791645,"about_ca_system_score_gemma":0.0001753677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002855194,"about_ca_topic_score_gemma":0.00005772991,"domain_scores_codex":[0.9982401,0.00009843845,0.0004364995,0.0004566696,0.0004191019,0.0003492307],"domain_scores_gemma":[0.9989113,0.0001309593,0.0001967082,0.0006293719,0.00001587827,0.0001158026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000354624,0.002428743,0.9494969,0.0003101272,0.0003384342,0.0001409561,0.0006394872,0.0002761403,0.04429469,0.00004921132,0.0006503668,0.00102038],"study_design_scores_gemma":[0.005141477,0.0002482579,0.9692368,0.0002847433,0.002244464,0.000004249894,0.0005316843,0.00006957282,0.02041046,0.00002489112,0.001587494,0.0002159055],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856803,0.01102222,0.000009762398,0.0006118498,0.0001307878,0.0006073766,0.0002293135,0.00001130578,0.001697054],"genre_scores_gemma":[0.9968541,0.0006767196,0.00004125174,0.001084671,0.00003945272,0.0001799084,0.0001024757,0.00002889887,0.0009924738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02388423,"threshold_uncertainty_score":0.7067299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2504181072","doi":"10.1158/2159-8290.cd-15-1227","title":"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types","year":2016,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency; Public Health Ontario; McGill University and Génome Québec Innovation Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute for Health and Care Research; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Research UK; Francis Crick Institute; U.S. Department of Defense; Breast Cancer Research Foundation; World Health Organization; Roswell Park Cancer Institute","keywords":"Prostate cancer; Genome-wide association study; Ovarian cancer; Breast cancer; Biology; Cancer; Computational biology; Genetic association; Genetics; Prostate; Genome; Bioinformatics; Oncology; Medicine; Single-nucleotide polymorphism; Gene; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.06243794438319494,"gpt":0.3644030428553883,"spread":0.3019650984721933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003666354,0.0002365017,0.0006114426,0.00003212833,0.0001046795,0.00002417557,0.0001370468,0.0001381128,0.0002365964],"category_scores_gemma":[0.0004931946,0.0001593931,0.0002240632,0.0001006912,0.0001249541,0.00002948793,0.0001677863,0.00005703929,0.000003220411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003961009,"about_ca_system_score_gemma":0.0002501556,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006852187,"about_ca_topic_score_gemma":0.01687679,"domain_scores_codex":[0.9983009,0.0001777638,0.0004480359,0.0005609358,0.0001690506,0.0003432782],"domain_scores_gemma":[0.9986063,0.0001722558,0.0005410141,0.0002942475,0.0002960548,0.00009011613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008839164,0.00002102006,0.6174104,0.0000290023,0.003929942,1.809023e-7,0.00008109385,0.0002993745,0.3524826,9.803165e-7,0.02464241,0.001014625],"study_design_scores_gemma":[0.001679133,0.00007011204,0.917444,0.00003595067,0.002656514,0.000001112384,0.0001232219,0.00001363259,0.06531011,0.0001959234,0.0120794,0.0003908736],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9325789,0.0598809,0.0003822019,0.003602299,0.0001924818,0.000257535,0.003067709,0.000008120095,0.00002982235],"genre_scores_gemma":[0.9612753,0.0166625,0.0000784945,0.0003319405,0.0002317766,0.0001909987,0.0001422004,0.00002338296,0.02106339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3000337,"threshold_uncertainty_score":0.9997613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143505663","doi":"10.1158/2159-8290.cd-13-0117","title":"Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Wellcome Trust; National Cancer Institute; Celgene","keywords":"Azacitidine; Methyltransferase; DNA methylation; Cancer research; Diffuse large B-cell lymphoma; Lymphoma; Decitabine; Epigenetics; Medicine; Biology; Methylation; Internal medicine; DNA; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.01505177842079885,"gpt":0.2707523915528284,"spread":0.2557006131320296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102544,0.0001634371,0.0002970882,0.0001095066,0.00004545486,0.00003105888,0.0001172267,0.0001049475,0.000419876],"category_scores_gemma":[0.00002838236,0.0001328245,0.0001101633,0.0002657047,0.00007064685,0.0001714864,0.0000398017,0.00009001575,0.00006718812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003454643,"about_ca_system_score_gemma":0.0007421222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004182152,"about_ca_topic_score_gemma":0.00001150598,"domain_scores_codex":[0.9987372,0.00004581553,0.0002348117,0.000274344,0.0003569534,0.0003508582],"domain_scores_gemma":[0.9990824,0.00005978545,0.0001004226,0.0004311903,0.0002011845,0.0001250419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004456423,0.002310849,0.006495005,0.0003053218,0.0001082065,0.00002420317,0.0002996078,0.00003961908,0.9703424,0.000413494,0.005006708,0.01420893],"study_design_scores_gemma":[0.01548635,0.0002057386,0.01636533,0.00009889434,0.00002888304,0.000002968708,0.0001312127,0.004075826,0.9620442,0.0002601367,0.00113517,0.0001652739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909787,0.001133276,0.005349763,0.0008265934,0.0001205589,0.0007377536,0.00004403352,0.00003781055,0.0007715816],"genre_scores_gemma":[0.9942108,0.001325983,0.0002614296,0.001620212,0.0001503223,0.0001461655,0.00006908199,0.00005056284,0.002165418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01504071,"threshold_uncertainty_score":0.5416425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146971577","doi":"10.1158/2159-8290.cd-12-0107","title":"CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues","year":2012,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Stromal cell; Stroma; Carcinogenesis; Cancer research; Biology; Extracellular matrix; Tumor progression; Angiogenesis; CD36; Cell biology; Cancer; Immunology; Receptor; Immunohistochemistry; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01459909841721308,"gpt":0.296734841471814,"spread":0.2821357430546009,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000791277,0.0002099752,0.0003371266,0.00006222074,0.0000953972,0.00007979846,0.00006038744,0.00007943511,0.0001420702],"category_scores_gemma":[0.00002631019,0.0001632795,0.00008558243,0.0001450388,0.0001286289,0.0005869524,0.00007622686,0.000198201,0.000003826417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009226987,"about_ca_system_score_gemma":0.00005131639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002302359,"about_ca_topic_score_gemma":0.00004971978,"domain_scores_codex":[0.9987988,0.00002683064,0.000187133,0.0003495358,0.0002315336,0.0004061004],"domain_scores_gemma":[0.9992693,0.00003163931,0.0001087208,0.0002910722,0.00003847165,0.0002608022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000590681,0.000381887,0.8621774,0.0002091221,0.0001357835,0.00002176081,0.0004315711,0.000001213688,0.1134556,0.00002208142,0.004387116,0.01818577],"study_design_scores_gemma":[0.002044298,0.0003235886,0.8351979,0.0005118072,0.0003321613,0.00002926631,0.000352479,0.0000825079,0.1364154,0.00002492811,0.02429296,0.0003927676],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877465,0.01078515,0.00003509036,0.0002275068,0.0003498095,0.0005785386,0.0001171825,0.0001037666,0.00005644639],"genre_scores_gemma":[0.9974494,0.0008215773,0.0002824259,0.0001463164,0.0004057218,0.0001577633,0.0001046203,0.00003501165,0.0005971738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02697956,"threshold_uncertainty_score":0.6658343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3151543485","doi":"10.1158/2159-8290.cd-20-1677","title":"Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; European Hematology Association; National Heart, Lung, and Blood Institute; Stand Up To Cancer; Doris Duke Charitable Foundation","keywords":"Persistence (discontinuity); Profiling (computer programming); Cell; Computational biology; Term (time); Biology; Cell biology; Genetics; Computer science; Physics; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.07317010384896924,"gpt":0.3271938155873689,"spread":0.2540237117383997,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001607677,0.0002606083,0.0006013202,0.0001231475,0.00007219247,0.0000379171,0.0001321157,0.0001389724,0.0004029716],"category_scores_gemma":[0.0000860069,0.000202783,0.0002123061,0.0003068116,0.0002069385,0.0002303889,0.00007647368,0.000352311,5.445524e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002045663,"about_ca_system_score_gemma":0.0004862549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001525185,"about_ca_topic_score_gemma":0.00007704713,"domain_scores_codex":[0.9981855,0.0001171627,0.000456252,0.0004463118,0.0004880577,0.0003067627],"domain_scores_gemma":[0.9985495,0.0002441437,0.0003103433,0.0004211757,0.0003405756,0.0001342139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001485081,0.0002369942,0.2704699,0.0007011761,0.00006121965,0.00001121916,0.003613866,0.00005924734,0.723786,0.000005844079,0.00003055935,0.0008754579],"study_design_scores_gemma":[0.001404132,0.0003103248,0.03470771,0.0004389888,0.00009514775,0.000004840155,0.003456082,0.00003503464,0.9593183,0.00003082088,0.00002441617,0.0001742348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843094,0.01222397,0.0001637492,0.0001066003,0.0001939025,0.000650759,0.0001730277,0.00001587183,0.002162728],"genre_scores_gemma":[0.9894916,0.002014676,0.0004539217,0.0000585933,0.0001211807,0.00003030754,0.0001338067,0.00004485115,0.007651074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2357622,"threshold_uncertainty_score":0.8269249,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794723335","doi":"10.1158/2159-8290.cd-17-1004","title":"Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; GlaxoSmithKline","keywords":"Afatinib; ERBB3; Medicine; Cancer research; ErbB; Oncology; Cancer; Internal medicine; Erlotinib; Epidermal growth factor receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01720782505662348,"gpt":0.3378055771221455,"spread":0.320597752065522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001406216,0.0001944499,0.0002979101,0.0001951981,0.00008732561,0.00003976133,0.00009166095,0.00007170542,0.000421873],"category_scores_gemma":[0.00006142972,0.0001576673,0.00007772993,0.0007180217,0.00009611307,0.0002066753,0.00002093395,0.0001151008,0.00005948864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001284256,"about_ca_system_score_gemma":0.001255984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004350551,"about_ca_topic_score_gemma":0.003033716,"domain_scores_codex":[0.9987091,0.00007865372,0.0002229882,0.0003939533,0.0002267861,0.0003685117],"domain_scores_gemma":[0.9992284,0.00005933969,0.00005269716,0.0003503192,0.000131904,0.0001773284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.05907571,0.0008091907,0.2274148,0.00009282739,0.001326969,0.0002735512,0.020029,0.0003722646,0.4485559,0.0001081642,0.1724804,0.06946124],"study_design_scores_gemma":[0.01121651,0.00194239,0.7097153,0.0005729189,0.0001532083,0.00001104047,0.0006617872,0.00008599021,0.06208215,0.00007814767,0.2129655,0.0005149989],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868492,0.002183093,0.00005526241,0.005140058,0.0007382003,0.0008729468,0.0001407909,0.0001257758,0.003894668],"genre_scores_gemma":[0.9856066,0.0004256925,0.0002587816,0.005895676,0.0003742644,0.0005135041,0.00003670947,0.00004464915,0.006844133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4823005,"threshold_uncertainty_score":0.657676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2583051589","doi":"10.1158/2159-8290.cd-16-0330","title":"The Genetic Basis of Hepatosplenic T-cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Hotel Dieu Hospital","funders":"National Cancer Institute","keywords":"Exome sequencing; Genetics; Biology; Gene; Mutation; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.01252762656552232,"gpt":0.2407456703583194,"spread":0.2282180437927971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006276292,0.0001177382,0.0001942357,0.00001580208,0.0008922914,0.00004164029,0.0004509213,0.00008550529,0.00005421215],"category_scores_gemma":[0.00002640904,0.00006983117,0.0001237139,0.00002195932,0.0006846991,0.00008879098,0.0002039512,0.00006666424,0.00008673085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003272307,"about_ca_system_score_gemma":0.0001003541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009280532,"about_ca_topic_score_gemma":0.0004351189,"domain_scores_codex":[0.9993293,0.00003885015,0.0001701327,0.0001771582,0.0000286445,0.0002559068],"domain_scores_gemma":[0.999108,0.00007533175,0.0002051292,0.0005677363,0.00003404347,0.000009761094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004190878,0.000273939,0.304777,0.0001301673,0.000870389,0.000007993248,0.0006761079,0.00001025804,0.5459332,0.001231709,0.05071008,0.09496012],"study_design_scores_gemma":[0.002260062,0.0001026096,0.3122694,0.00006360822,0.0001534372,0.000006729971,0.0003608029,0.000002153501,0.5122294,0.0003311945,0.1719592,0.0002613812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9302631,0.06166859,0.00001653103,0.000428304,0.001871514,0.0000988894,0.0000765688,0.00001208152,0.005564404],"genre_scores_gemma":[0.9570971,0.01129403,0.00000470996,0.00005536358,0.00006434548,0.00003501301,0.000002757405,0.00001051441,0.03143613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1212491,"threshold_uncertainty_score":0.6862875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789786349","doi":"10.1158/2159-8290.cd-17-1215","title":"PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Congressionally Directed Medical Research Programs; UCI Beall Applied Innovation; National Institute of Biomedical Imaging and Bioengineering; National Center for Research Resources; National Institute of General Medical Sciences; Canada Research Chairs; National Institutes of Health; National Cancer Institute; Genome Canada; American Cancer Society","keywords":"Prostate cancer; AMPK; Cancer research; Pinocytosis; Cancer cell; Cancer; Biology; Cell biology; Cell; Internal medicine; Medicine; Biochemistry; Protein kinase A; Phosphorylation; Endocytosis","retraction":null,"screen_n_in":null,"score":{"opus":0.006486580942440402,"gpt":0.2456510913190878,"spread":0.2391645103766474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001157794,0.0001539502,0.0001550033,0.00005738973,0.00007788013,0.00006745093,0.0000744201,0.00007002814,0.00001377862],"category_scores_gemma":[0.00001272964,0.0001406176,0.00002539513,0.0001337629,0.000151754,0.00003474299,0.00008072052,0.00007209504,8.022366e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003294735,"about_ca_system_score_gemma":0.0001321138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002922599,"about_ca_topic_score_gemma":0.0002460891,"domain_scores_codex":[0.998994,0.00002760358,0.0001566308,0.0004177879,0.000102559,0.000301437],"domain_scores_gemma":[0.999618,0.000004225435,0.00007803342,0.0001709228,0.00006002514,0.00006879245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002511402,0.00008273724,0.01596583,0.0002158893,0.00004606258,0.000001933116,0.001950081,0.0001019294,0.6713114,0.0002129348,0.001147512,0.3087126],"study_design_scores_gemma":[0.001068291,0.0001021541,0.01984779,0.0001747101,0.00002579418,0.000001148319,0.0001725566,0.0001582019,0.8497311,0.0002759001,0.1280899,0.0003524952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8789344,0.120152,0.00009660341,0.00006664342,0.0002955641,0.0002462825,0.00005491826,0.000006127292,0.0001475514],"genre_scores_gemma":[0.9041364,0.09457009,0.00003622397,0.0004262918,0.0004317124,0.0001222726,0.00001520239,0.00001996623,0.0002418353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3083601,"threshold_uncertainty_score":0.5734221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3146811394","doi":"10.1158/2159-8290.cd-20-1503","title":"Synthetic Lethality in Cancer Therapeutics: The Next Generation","year":2021,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aegera Therapeutics (Canada); Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Druggability; Synthetic lethality; CRISPR; Computational biology; Suppressor; Carcinogenesis; Biology; Loss function; Drug discovery; Drug development; Function (biology); Gene; Phenotype; Cancer research; Bioinformatics; Drug; DNA repair; Genetics; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.1006643734273958,"gpt":0.4061631181182451,"spread":0.3054987446908493,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001452683,0.0002864129,0.0005041086,0.00003195737,0.00004708442,0.0001019072,0.0002533658,0.0002380882,0.00004181308],"category_scores_gemma":[0.00001453297,0.0002012718,0.0002852832,0.0001443657,0.00005201135,0.000005778892,0.0001062303,0.0002229747,0.000002465948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009776773,"about_ca_system_score_gemma":0.0005104104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001740405,"about_ca_topic_score_gemma":0.0007126686,"domain_scores_codex":[0.9987402,0.0001291585,0.0003059615,0.0004707285,0.0001130873,0.0002408447],"domain_scores_gemma":[0.9992704,0.00002126569,0.0000966335,0.0005523707,0.0000300123,0.00002931745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003261009,0.00003426774,0.0000409914,0.002009553,0.000254403,0.000003854796,0.0000482658,0.001079721,0.003615414,0.0000363406,0.001001369,0.9918725],"study_design_scores_gemma":[0.00007435273,0.00001238958,0.00001390509,0.00174881,0.0002649133,0.000005813121,0.00002470864,0.00004395906,0.001588754,0.000002521748,0.9959394,0.0002804524],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008104453,0.9970561,0.0006929738,0.0000854254,0.000840785,0.0003201992,0.00009955349,0.000004887804,0.0000895886],"genre_scores_gemma":[0.001832896,0.9952324,0.00001353424,0.0002067986,0.001170876,0.0005394283,0.0002055444,0.00004906853,0.0007494261],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9949381,"threshold_uncertainty_score":0.8207626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3206007153","doi":"10.1158/2159-8290.cd-21-0506","title":"Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis","year":2021,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Biology; Molecular mimicry; Epigenetics; Cancer; Mimicry; Histone; Immune system; Immunology; Genetics; DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.03439607338499383,"gpt":0.3369066096164206,"spread":0.3025105362314268,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000263786,0.00029949,0.000650824,0.00005324945,0.00005243318,0.00007393515,0.0001476017,0.0001783917,0.0000132259],"category_scores_gemma":[0.00002537895,0.0002107374,0.0001639361,0.0001007228,0.0001197215,0.00000475402,0.0001617704,0.0001790265,2.627203e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005395575,"about_ca_system_score_gemma":0.0002825889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000169713,"about_ca_topic_score_gemma":0.00007193043,"domain_scores_codex":[0.9987029,0.0002169003,0.0002731668,0.0004583687,0.00009413466,0.0002545046],"domain_scores_gemma":[0.9994606,0.00004690449,0.00009076788,0.0003374478,0.0000181084,0.00004619169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007081722,0.0000378442,0.0001607663,0.002290758,0.0005421588,0.00003504043,0.0002020171,0.00004212142,0.009344823,0.00001786305,0.0005140072,0.9861044],"study_design_scores_gemma":[0.001303641,0.00008614477,0.00007472035,0.001659522,0.0002007411,0.0000213024,0.00005997064,0.000003142899,0.004673729,0.000005061504,0.9915389,0.0003730752],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04728367,0.9517154,0.00005801997,0.00005032767,0.0002294968,0.0004371472,0.000203957,0.000003110104,0.00001887862],"genre_scores_gemma":[0.009019055,0.9898166,0.00001568109,0.00012111,0.0002335151,0.0003525144,0.00008936987,0.00004612088,0.0003060542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.991025,"threshold_uncertainty_score":0.859362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3170908410","doi":"10.1158/2159-8290.cd-21-0145","title":"Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Cancer Institute; Ontario Institute for Cancer Research; National Institutes of Health; Canadian Cancer Society; Damon Runyon Cancer Research Foundation","keywords":"Enhancer; Stem cell; Biology; Cancer research; Leukemia; Lineage (genetic); Cell biology; Gene; Genetics; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.02139903256790399,"gpt":0.3059097712941333,"spread":0.2845107387262293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002197468,0.0003164003,0.0005957993,0.0001485321,0.00008855013,0.0001125877,0.0002391477,0.0002348975,0.0004593224],"category_scores_gemma":[0.00004799918,0.0002865275,0.0002302144,0.0006084639,0.0001353194,0.0004536734,0.0003343156,0.0005965999,0.00009357944],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02468153,"about_ca_system_score_gemma":0.02082837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001138034,"about_ca_topic_score_gemma":0.0003935287,"domain_scores_codex":[0.9970509,0.00009424562,0.0005269026,0.0008253632,0.0007361773,0.0007664555],"domain_scores_gemma":[0.9985182,0.0001430368,0.0001310262,0.0008188092,0.000146998,0.0002419839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007327106,0.0003313429,0.003883614,0.001275835,0.0001024745,0.00307813,0.002212554,0.00186669,0.959223,0.00001852895,0.005692694,0.02158239],"study_design_scores_gemma":[0.01177418,0.00008190583,0.00156674,0.001565877,0.00007160339,0.00008967458,0.001082098,0.001874484,0.9746531,0.00001742586,0.006875809,0.0003471471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737403,0.01983321,0.000297006,0.0001631133,0.0006801297,0.0003900709,0.00002649167,0.00006699871,0.004802659],"genre_scores_gemma":[0.9665864,0.005645535,0.0002062104,0.0006728792,0.000685282,0.0001702474,0.00004974537,0.00008423987,0.02589949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02123524,"threshold_uncertainty_score":0.9999587,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403694618","doi":"10.1158/2159-8290.cd-24-0708","title":"The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development","year":2024,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Drug development; Clinical trial; Medicine; Identification (biology); Modalities; Computational biology; Drug; Drug discovery; Bioinformatics; Pharmacology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2113580981287041,"gpt":0.491369090281659,"spread":0.2800109921529549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000732404,0.0003910784,0.002014848,0.0002092812,0.00006835789,0.00009644948,0.0006168303,0.0002121279,0.0002231398],"category_scores_gemma":[0.0001975038,0.0002490582,0.0006241359,0.0005797289,0.0004239522,0.00008828157,0.0003342845,0.001032621,0.000104703],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006936693,"about_ca_system_score_gemma":0.01031092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008683527,"about_ca_topic_score_gemma":0.0002125023,"domain_scores_codex":[0.9966878,0.0001878788,0.001123381,0.0005774091,0.000958117,0.0004653911],"domain_scores_gemma":[0.9977548,0.0005769989,0.0004891076,0.0008527188,0.0001616278,0.0001647494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008031198,0.00005398622,0.00005005687,0.0280249,0.001627026,0.00006293541,0.0004738049,0.000001406167,0.00004792201,0.0001349363,0.01549229,0.9539504],"study_design_scores_gemma":[0.0002652172,0.00003548591,0.0001119036,0.07731479,0.001293,0.000006629206,0.0001565848,0.000001964429,0.0002284782,0.0001113269,0.9202614,0.0002131485],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006601325,0.9951335,0.00001170077,0.0006841398,0.001018279,0.0008369683,0.0008601842,0.00002293105,0.0007721726],"genre_scores_gemma":[0.0003163707,0.990557,0.00005846835,0.00004315552,0.0004641436,0.0002022667,0.000207559,0.0001247894,0.008026209],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9537373,"threshold_uncertainty_score":0.9999962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952632749","doi":"10.1158/2159-8290.cd-19-0061","title":"Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling","year":2019,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; Children's Cancer Research Fund; National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; National Cancer Institute; National Institutes of Health; Bear Necessities Pediatric Cancer Foundation; Cancer Prevention and Research Institute of Texas; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Biology; Polyunsaturated fatty acid; Stem cell; Cancer research; Glioma; Cell biology; Downregulation and upregulation; Fatty acid; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01204866861162243,"gpt":0.2389533652382087,"spread":0.2269046966265863,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001356435,0.0003606946,0.0004064822,0.00009801394,0.00009014312,0.0001563423,0.0003533392,0.0002040493,0.0004226827],"category_scores_gemma":[0.00001194465,0.0003348737,0.0002099841,0.0002698941,0.00006431698,0.00003786513,0.0001381332,0.0001326727,0.0001523987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000095954,"about_ca_system_score_gemma":0.0003832704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001064689,"about_ca_topic_score_gemma":0.00005766116,"domain_scores_codex":[0.997942,0.0000600243,0.0003412751,0.0008222067,0.0002587297,0.0005757469],"domain_scores_gemma":[0.9989005,0.00002238069,0.0001116332,0.000653025,0.0001170754,0.000195358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002963638,0.00005397505,0.001146949,0.0000810066,0.0000748934,6.723529e-7,0.0001594213,0.00006328461,0.968226,0.00002866957,0.02417178,0.005696984],"study_design_scores_gemma":[0.0003503474,0.0001523348,0.00104892,0.00007868231,0.00003904021,0.000005671438,0.0002511439,0.000002981543,0.798991,0.000003853756,0.1986515,0.0004245295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788301,0.009518311,0.000589324,0.0001414985,0.008643012,0.0005380339,0.0003258012,0.00003656317,0.001377342],"genre_scores_gemma":[0.9862198,0.001001274,0.0001580599,0.000423184,0.007022619,0.0002375136,0.00008393246,0.00008266367,0.004770954],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1744798,"threshold_uncertainty_score":0.9999104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3176308859","doi":"10.1158/2159-8290.cd-20-1647","title":"Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":177,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; National Cancer Institute; Genentech; Fondation contre le Cancer; Servier; European Organisation for Research and Treatment of Cancer; National Institute for Health and Care Research; Cancer Research UK; G1 Therapeutics; Koning Boudewijnstichting; Puma Biotechnology; Sanofi; Breast Cancer Research Foundation; PTC Therapeutics; Fondation Cancer; National Breast Cancer Foundation; Clovis Oncology; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; GlaxoSmithKline; Pfizer; Cancer Research Institute","keywords":"Breast cancer; Transcriptome; Oncology; Medicine; Cancer; Computational biology; Biology; Internal medicine; Genetics; Bioinformatics; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.0225287982106395,"gpt":0.2862496692165856,"spread":0.2637208710059461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007938778,0.0001517193,0.0002156637,0.00004523914,0.00004433146,0.00008215252,0.0001181174,0.00005318471,0.00002146729],"category_scores_gemma":[0.00001884196,0.0001292034,0.00006922552,0.00009783776,0.0002069542,0.00001817596,0.0001545111,0.00007915705,7.862619e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003930329,"about_ca_system_score_gemma":0.0002430865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001720564,"about_ca_topic_score_gemma":0.003645916,"domain_scores_codex":[0.9991553,0.00005433934,0.0002178216,0.0003191455,0.00009672836,0.0001566543],"domain_scores_gemma":[0.9995722,0.00003676965,0.0001014573,0.000167827,0.00007970508,0.00004209591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003131827,0.00005015368,0.08890182,0.00005230021,0.0004601041,0.00001949282,0.0002143064,0.0009413795,0.8991895,0.0002753128,0.0001143842,0.009468069],"study_design_scores_gemma":[0.001661291,0.00004556566,0.8233374,0.0001330837,0.0002603598,0.00009543864,0.001103913,0.000166763,0.1712434,0.0002732252,0.001352787,0.0003268003],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9699823,0.02451767,0.001766275,0.000943567,0.0001566108,0.00010566,0.002464433,0.000002258209,0.0000612854],"genre_scores_gemma":[0.9879353,0.01084194,0.0001797584,0.0006583544,0.0001302369,0.00005016068,0.0001605264,0.00001862089,0.00002511336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7344356,"threshold_uncertainty_score":0.5268762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038208403","doi":"10.1158/2159-8290.cd-14-1246","title":"Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy","year":2015,"lang":"en","type":"review","venue":"Cancer Discovery","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Synovial sarcoma; Wnt signaling pathway; Cancer research; SWI/SNF; Biology; Chromatin remodeling; Epigenetics; Psychological repression; Cancer; Sarcoma; Carcinogenesis; Fusion gene; Cell biology; Medicine; Pathology; Genetics; Signal transduction; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.138404724894596,"gpt":0.4260366416005176,"spread":0.2876319167059216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001377685,0.0006878557,0.002414376,0.0001733613,0.00007650035,0.0001711543,0.0002446392,0.0002451378,0.0001893985],"category_scores_gemma":[0.0001091199,0.0004660114,0.0008578215,0.0003281495,0.00005876589,0.0002027034,0.0001010599,0.0002076809,0.0001419929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001159822,"about_ca_system_score_gemma":0.00409458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000560698,"about_ca_topic_score_gemma":0.00009642498,"domain_scores_codex":[0.9976315,0.00006071902,0.0005733659,0.0007709567,0.0004393828,0.0005240051],"domain_scores_gemma":[0.9982319,0.0001631173,0.0002707018,0.0007256411,0.0001218961,0.0004867513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003666824,0.0003541875,0.000100519,0.00213496,0.0007979798,0.00005301121,0.0001634569,7.031302e-7,4.863775e-7,0.0002050168,0.0911951,0.9046279],"study_design_scores_gemma":[0.002000808,0.0007799544,0.00004304167,0.01110884,0.001595985,0.0000464497,0.00003593027,1.030064e-7,0.00002444441,0.0003764513,0.9835238,0.0004642242],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001626213,0.9910209,0.0000521955,0.001410828,0.001528871,0.004200165,0.0009082623,0.00005512733,0.0006610295],"genre_scores_gemma":[0.00001857477,0.9860449,0.000214298,0.001035037,0.002693039,0.00379076,0.0006006675,0.0001608697,0.005441806],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9041637,"threshold_uncertainty_score":0.9997792,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}